Keryx Biopharmaceuticals Inc - New York City, New York 10022

Keryx Biopharmaceuticals Inc is categorized under in New York City, NY .

Business Name: Keryx Biopharmaceuticals Inc
Contact Person: Ron Bentsur, Chief Executive Officer
Address: 750 Lexington Avenue Floor 20, New York City, New York 10022
Phone Number: (212) 531-5965
Website Address: keryx.com
Annual Revenue (USD): Unknown
Founding Year: 1997
Location Type: Headquarters
Employee Number: 1 to 4
Business Type: B2B & B2C
Business Category:
SIC Code: 2834
NAICS Code: 3254120
Share This Business:
Related Businesses: Lightlake Therapeutics Inc - New York City, NY 10022
Krele LLC - New York City, NY 10022
Melinta Pharmaceuticals Inc - New York City, NY 10022
Aoi Pharma Inc - New York City, NY 10022
Niobe Ventures LLC - New York City, NY 10022
Ohr Pharmaceutical Inc - New York City, NY 10022
Stemline Therapeutics Inc - New York City, NY 10022
Bristol-Myers Squibb Company - New York City, NY 10022
Forest Laboratories Inc - New York City, NY 10022
Tonix Pharmaceuticals Inc - New York City, NY 10022
Danube Pharmaceuticals Inc - New York City, NY 10022

The company Keryx Biopharmaceuticals Inc provides BOTH services in the form of from its headquarters in New York. 1 to 4 employees work for Keryx Biopharmaceuticals Inc, and the business now earns Unknown per annum.

Keryx Biopharmaceuticals Inc was launched in 1997 and is classified under SIC code and category 2834 , and NAICS number and grouping 3254120 . To contact Keryx Biopharmaceuticals Inc, please call Ron Bentsur, Chief Executive Officer with the phone number (212) 531-5965 or visit its headquarters at 750 Lexington Avenue Floor 20 in New York City, New York 10022.

The location of the headquarters can also be found using the coordinates 40.762509,-73.968061. Read more details about this business on the webpage keryx.com or follow the company’s social media accounts, on Twitter and on Facebook.